Targeted Cell Therapies is an early-stage Massachusetts-based biopharmaceutical company that is using its powerful technology platform for the development of oral biotherapeutics for a broad range of human conditions. Targeted Cell Therapies technology permits the conversion of injectables into oral drugs, avoiding the usual need for injection or infusion.
An increasing number of breakthrough biologics are on the horizon, but as injectables they will require delivery in monitored and costly settings. As infusion drugs they are disruptive to normal lifestyle of adults and children.
Our oral delivery technology solves a key hurdle for delivery of these biologics